KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Goodwill & Intangibles: 2022-2025

Historic Goodwill & Intangibles for Halozyme Therapeutics (HALO) over the last 4 years, with Sep 2025 value amounting to $765.4 million.

  • Halozyme Therapeutics' Goodwill & Intangibles fell 8.49% to $765.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $765.4 million, marking a year-over-year decrease of 8.49%. This contributed to the annual value of $818.7 million for FY2024, which is 7.99% down from last year.
  • According to the latest figures from Q3 2025, Halozyme Therapeutics' Goodwill & Intangibles is $765.4 million, which was down 2.27% from $783.1 million recorded in Q2 2025.
  • Over the past 5 years, Halozyme Therapeutics' Goodwill & Intangibles peaked at $1.2 billion during Q2 2022, and registered a low of $765.4 million during Q3 2025.
  • In the last 3 years, Halozyme Therapeutics' Goodwill & Intangibles had a median value of $854.2 million in 2024 and averaged $854.6 million.
  • Data for Halozyme Therapeutics' Goodwill & Intangibles shows a maximum YoY decreased of 21.08% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Halozyme Therapeutics' Goodwill & Intangibles stood at $955.7 million in 2022, then fell by 6.91% to $889.7 million in 2023, then decreased by 7.99% to $818.7 million in 2024, then fell by 8.49% to $765.4 million in 2025.
  • Its Goodwill & Intangibles was $765.4 million in Q3 2025, compared to $783.1 million in Q2 2025 and $800.9 million in Q1 2025.